The TV repeats and old songs that help people with dementia

Familiar old films or a favourite festive song can help those with dementia reconnect with family and friends.

Share Button

Health24.com | It’s not abnormal to poop during sex – but don’t let it happen to you

You probably thought ‘she-pooped-during-sex’ stories were urban legends. But as it turns out, the human body actually is that evil. “It can happen, and it’s not abnormal,” says sex therapist Dr Lisa Lawless, founder of Holisticwisdom.com.

Here’s how that works: If you have a massive orgasm (woo!) and bear down, poop can slip out, kind of like childbirth, says Lawless.

That being said, just because it’s “not abnormal” that doesn’t mean it’s common — you’re actually much more likely to fart in this scenario, says Lawless. So, that’s kind of comforting?

Another factor in the orgasm-poop connection are hormone-like compounds called prostaglandins, says gynaecologist Dr Diana Hoppe, author of Healthy Sex Drive, Healthy You. When you orgasm, your body releases those compounds, causing the uterus to contract and increase blood flow to your lower pelvis. This is great for lubrication, but makes it tough to hold your pee or poop, she says.

“This can lead to unwanted loss of urine and or stool,” says Hoppe. Um, yeah, “unwanted” might be an understatement.

If this happens to you, it’s important to keep your chill.

READ MORE: This Is What Happens To Your Body When You Hold In Your Poop

“If you feel awkward and bad, your partner’s going to feel awkward and bad,” says Lawless. Your move: Muster up some self-confidence, laugh it off, and explain that you were so turned on you lost control, she says. (Then send him out for late-night fro-yo while you change the sheets and, um, shower.)

And to reduce the risk of this ever happening, get your kegel on. These exercises help tighten the pelvic floor, so you can control your bladder and bowels. Another helpful hint: Empty your tank before sex, says Lawless. More preparation = less poop.

This article was originally published on www.womenshealthsa.co.za

Image credit: 

NEXT ON HEALTH24X

Share Button

Health24.com | High blood pressure during pregnancy tied to future heart risks

Pregnancy-related high blood pressure puts women at higher risk of heart disease later on, new research suggests.

In the study, researchers analysed an average of seven years of follow-up data on more than 220 000 women in the United Kingdom. Those who had gestational high blood pressure or preeclampsia in at least one pregnancy had stiffer arteries, and two to five times the rate of chronic high blood pressure later on, the findings showed.

Chronic high blood pressure

These women were more likely to develop heart problems, including coronary artery disease, heart failure and valve disease, according to the report published online in the Journal of the American College of Cardiology.

Up to half the risk was driven by chronic high blood pressure, the investigators found. That “implies that treating high blood pressure may be especially important in this population,” said study lead author Dr Michael Honigberg. He’s a cardiologist at Massachusetts General Hospital in Boston.

Future research could assess new ways of treating high blood pressure (“hypertension”) or simply treating it more aggressively in women who have had it at least once during pregnancy, Honigberg suggested.

“Research over the past decade has shown there are sex-specific risk factors for cardiovascular disease among women,” Honigberg said in a hospital news release. “But there were still some significant gaps in our understanding of those risks, and one gap is whether the elevated risk persists long-term after a hypertensive pregnancy, or whether other women ‘catch up’ as cardiovascular risk increases with age in the population overall.”

Asking about women’s history

Doctors are still figuring out how to predict and prevent high blood pressure problems during pregnancy, he noted. “But what we can do is look ahead and try to mitigate the risk of these women developing cardiovascular disease later in life,” Honigberg said.

That includes heart-healthy lifestyle changes such as exercise, eating a healthy diet, not smoking and controlling weight. Some women may also benefit from medication, he explained.

“You’d be shocked at how few physicians who aren’t obstetrician/gynaecologists – including cardiologists – ask their female patients if they’ve had a hypertensive disorder of pregnancy,” Honigberg said. “This research really underscores the importance of clinicians asking about this history, and of women sharing it.”

Image credit: iStock

NEXT ON HEALTH24X

Share Button

Cannabis-based medicine for epilepsy available on NHS from January

NHS England says access to Epidyolex has been fast-tracked and will be available from 6 January.

Share Button

Health24.com | How do we recognise familiar songs almost instantaneously?

It happens to everyone: A familiar song comes on the radio, and suddenly you recall every note and every word.

Now, new research has pinpointed exactly how long it takes people to recognise that favourite tune – just 0.1 to 0.3 seconds.

Song recognition revealed by pupil dilation

The study included five men and five women who each provided a list of five familiar songs that they associated with good memories.

The researchers then chose one of each participants’ songs and matched it with a song that was similar in tempo, melody, harmony, vocals and instrumentation, but was unfamiliar to the participant.

Each participant was randomly played 100 snippets (each less than a second) of both the familiar and unfamiliar song. The researchers monitored the participants’ electrical activity in the brain and their pupil diameter (a measure of arousal) while they listed to the song snippets.

Song recognition was first revealed by pupil dilation likely associated with increased arousal triggered by the familiar song, followed by brain activity related to memory retrieval, according to the study published online in the journal Scientific Reports.

A “control group” of people unfamiliar with any of the songs used in the study had no differences in responses to any of the songs, said the researchers at the University College London Ear Institute.

Therapeutic interventions

“Our results demonstrate that recognition of familiar music happens remarkably quickly,” study senior author Maria Chait said in a school news release.

“These findings point to very fast temporal circuitry and are consistent with the deep hold that highly familiar pieces of music have on our memory,” Chait added.

“Beyond basic science, understanding how the brain recognises familiar tunes is useful for various music-based therapeutic interventions,” she said.

“For instance, there is a growing interest in exploiting music to break through to dementia patients for whom memory of music appears well-preserved despite an otherwise systemic failure of memory systems,” Chait explained.

“Pinpointing the neural pathway and processes which support music identification may provide a clue to understanding the basis of this phenomenon,” Chait concluded.

Image credit: iStock

NEXT ON HEALTH24X

Share Button

‘My eating disorder took away magic of Christmas’

New advice is released to help those living with eating disorders over the festive season.

Share Button

The Priory: Children’s mental health ward inadequate

An inspection was carried out after concerns were raised by families and the public.

Share Button

Health24.com | How sleep deprivation dangerously drains the brain

If you feel like you can’t think straight after a sleepless night, new research suggests you are not imagining things.

The mental impacts of sleep deprivation are much more serious than previously believed, the study found.

Costly errors

“Our research showed that sleep deprivation doubles the odds of making placekeeping errors and triples the number of lapses in attention, which is startling,” said study author Kimberly Fenn. She directs the Sleep and Learning Lab at Michigan State University.

The researchers describe placekeeping as following several steps to complete a task, despite interruptions.

“Sleep-deprived individuals need to exercise caution in absolutely everything that they do, and simply can’t trust that they won’t make costly errors. Oftentimes – like when behind the wheel of a car – these errors can have tragic consequences,” Fenn said in a university news release.

In the study, 77 people stayed awake all night and 61 slept at home. Their ability to do two types of mental tasks were assessed in the evening and again the next morning.

One test assessed their reaction time to a stimulus and the other measured their placekeeping ability.

“After being interrupted there was a 15% error rate in the evening and we saw that the error rate spiked to about 30% for the sleep-deprived group the following morning,” said co-author Michelle Stepan, a doctoral candidate at Michigan State. “The rested participants’ morning scores were similar to the night before.”

Widespread deficits

The researchers said this study is one of the largest of its kind and the first to assess how sleep deprivation impacts placekeeping.

“Our findings debunk a common theory that suggests that attention is the only cognitive function affected by sleep deprivation,” Stepan said in the release.

“Some sleep-deprived people might be able to hold it together under routine tasks, like a doctor taking a patient’s vitals,” she noted. “But our results suggest that completing an activity that requires following multiple steps, such as a doctor completing a medical procedure, is much riskier under conditions of sleep deprivation.”

There are some tasks people can do on auto-pilot that may not be affected by a lack of sleep, but “sleep deprivation causes widespread deficits across all facets of life,” Fenn said.

The study was published online in the Journal of Experimental Psychology: General.

Image credit: iStock

Share Button

Strong change of course for muscle research

Anyone who climbs the 285 steps to the viewing platform of Berlin’s Siegessäule, or Victory Column, will probably have quite a few sore muscles the next day. Out-of-the-ordinary activities such as climbing lots of steps or even normal exercise can put significant strain on muscles. Such activities cause tiny tears in the muscle fibers, which the body then repairs on its own.

Even when injuries occur, the muscles activate an endogenous regeneration program: A reserve supply of muscle stem cells, known as satellite cells, reside around the muscle fibers and are essential for the repair of damaged muscle cells. These satellite cells produce new muscle fibers in a process which results in muscle regeneration. People maintain this ability well into old age. Researchers are particularly interested in these cells since they could provide targets for new therapeutic approaches for people with muscle diseases.

An overrated protein

Researchers previously assumed that a certain protein — the transcription factor PAX7 — plays a key role in muscle regeneration. “Cells from which new muscles arise have enormous potential for developing gene therapies to treat muscle atrophy. And PAX7 is actually considered a characteristic property of muscle-building satellite cells,” says Prof. Simone Spuler.

The scientist and physician is a research group leader at the Experimental and Clinical Research Center (ECRC), a joint institution of the Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC) and Charité — Universitätsmedizin Berlin, and heads the Myology Group at the MDC. Her team has now reported in the journal Nature Communications that it’s possible for muscles to grow and regenerate without PAX7. The study characterized a previously unknown subtype of satellite cells that could play an important role in the future development of gene therapies from muscle stem cells.

“The findings will certainly surprise many researchers in the field,” says Dr. Andreas Marg, a senior scientist in Spuler’s lab and the lead author of the study. He himself was initially guided by the assumption that the transcription factor was crucial for muscle growth. “I previously focused my research on PAX7-positive cells. Our findings lead us down a new path.”

New muscles despite a mutation

The research team owes the discovery to a young girl: Lavin has suffered from a genetic form of muscular dystrophy since birth and is the protagonist in the study. Lavin has all the muscles of a healthy person, but each of her muscles is very small. The musculature along her spine is particularly affected by the disease. Lavin’s arms and legs are strong, but she suffers breathing problems and has difficulty bending forward and holding her head up.

Gene analysis shows that the gene for PAX7 is damaged in Lavin; her cells can’t produce this protein. The University Hospital Munich discovered this in 2017. Soon thereafter, Spuler and Marg learned of this extremely rare mutation — one that had not been described before. Lavin traveled with her parents to the Berlin-Buch campus, where the scientists took a sample of her muscle tissue. Marg used a new procedure to filter out Lavin’s satellite cells and then implanted them in mice. He observed that new muscle fibers grew in the mice from Lavin’s cells — despite the absence of PAX7.

Spuler presumes that PAX7 is not equally important for every cell. This would explain why Lavin can walk and climb relatively well, but has hardly any strength in her diaphragm, which causes the breathing problems. “We could perhaps develop a gene therapy for Lavin using the CRISPR-Cas9 gene-editing tool,” says Spuler. “However, to repair the defective gene, CRISPR-Cas9 would have to specifically target the cells of the axial musculature, and that is not yet possible.” But Spuler’s lab is working intensively to figure out how to repair defective genes in muscle cells. For Lavin and her family, this research offers a small glimmer of hope that a suitable therapy will be found.

A new subtype of muscle stem cells

Marg and Spuler collaborated on the study with many colleagues at the MDC and with scientists from institutions abroad. Prof. Nikolaus Rajewsky’s research group at the Berlin Institute for Medical Systems Biology (BIMSB) compared Lavin’s cells with those donated by healthy people. Single-cell analysis, which looks at the activity of each cell individually, revealed a previously unknown cell population. In around 20 percent of the donors, the majority of the activated satellite cells also don’t produce any PAX7, even though the genetic information is present in the cells. The team instead discovered something else in those cells in which the transcription factor was missing: CLEC14A, a protein that is found in many blood vessel cells. This very protein was highly expressed in Lavin’s muscle stem cells.

The new study describes a previously unknown subtype of satellite cells. First, the researchers identified these cells in the stem cell niche, which is where the satellite cells reside. Second, PAX7 is not present in these cells. Third, other characteristic proteins such as CLEC14A are present instead. And fourth, new muscle fibers can be derived from this cell population.

Up to now, only cells with PAX7 have been considered as targets for gene therapy research involving satellite cells. The new study shows that the subtype discovered should also play a role in therapeutic development.

Share Button

Health24.com | How an experimental injection could protect against peanut allergy

People with peanut allergy must be constantly vigilant to avoid a life-threatening allergic reaction. But researchers report that a new drug injection might offer at least temporary protection against the most severe reactions.

Just one shot of an experimental antibody treatment allowed people with severe peanut allergy to eat about one peanut’s worth of peanut protein two weeks later, the study found.

Sharply rising numbers

The drug is like “a protective blanket” shielding people from accidental peanut exposure, said study senior author Dr Kari Nadeau, director of the Sean N. Parker Center for Allergy and Asthma Research at Stanford University in California.

Peanut allergy affects an estimated 2.5% of American children, and that number has risen sharply over the past decade, according to the American College of Allergy, Asthma and Immunology (ACAAI).

Children and adults with a peanut allergy are at risk of having a sudden and severe allergic reaction (anaphylaxis) that can be life-threatening if they consume even small amounts of peanuts.

The problem is that peanuts are in many foods, such as candy, cereal, baked goods, sauces, marinades and even in ice cream, according to the ACAAI.

That means people with peanut allergies have to be extra-careful about what they eat at home, and often have to limit the places they’ll eat at away from home. For example, many Asian foods are made with peanuts or peanut sauces, and possibly fried in peanut oil.

Besides avoiding foods with peanuts, the only current treatment for peanut allergy is oral immunotherapy. This treatment requires people to eat tiny bits of the food they’re allergic to at their doctor’s office. The amount of the offending food is increased over time. Treatment can take six months to a year, and they’re at risk of an allergic reaction during the process, the study authors explained.

Dramatic effect

The drug tested in the trial works in a different way. Called etokimab, the drug interferes with the action of a substance called interleukin-33 (IL-33). IL-33 triggers a cascading response that causes an allergic reaction when exposed to an allergen, such as a peanut.

The researchers tested the new medication on 15 adults with a severe peanut allergy. They were given a single injection of etokimab. Another five people with severe peanut allergies received a placebo injection.

Fifteen days later, they all consumed a small amount of peanut protein under medical supervision. They were given the food challenge again 45 days after the drug injection.

At 15 days, 73% of those treated were able to eat the equivalent of protein from one peanut. By day 45, just 57% who received the drug were able to pass the food challenges. People given the placebo couldn’t tolerate the peanut protein at either time.

“We were surprised to see an effect that was so dramatic,” Nadeau said.

Because this was a small, phase 2 clinical trial, Nadeau said larger studies that include younger patients and patients from more than one medical centre are still needed.

Food allergies becoming more common

A lot of questions remain, too. For example, is there an additive effect after more than one shot? Will the drug last a different amount of time for different people? And does it work for other types of food allergies? Nadeau said in theory, it should work for other food allergies as well.

The new medication appeared to be well-tolerated, and no serious side effects were reported.

The drug has also shown promise in treating asthma, Nadeau said.

Dr Noah Stern is chief of otolaryngology at DMC Harper University Hospital in Detroit. He said though the study is “exciting and important, it’s really just a starting point”. He was not involved with the research.

“Food allergies are becoming more and more common, so we need many tools to treat food allergies, and this study seems to show this drug might be a good tool for treating peanut allergy,” Stern said. But he added that the study was small and the drug is not available outside of clinical trials.

Cost is another concern, he pointed out. Biologic drugs like this can cost thousands of dollars a month.

Results of the study were published in the journal JCI Insight.

Image credit: iStock

Share Button